Article
Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
2 May 2012
Abstract excerpt
The success of adoptive T cell gene transfer for treatment of cancer and HIV is predicated on generating a response that is both durable and safe. We report long-term results from three clinical trials to evaluate gammaretroviral vector-engineered T cells for HIV. The vector encoded a chimeric antigen receptor (CAR) composed of CD4 linked to the CD3ζ signaling chain (CD4ζ). CAR T cells were detected in 98% of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
